SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Boston Scientific (BSX) Any Comments???
BSX 97.82-1.1%12:02 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jacob Snyder who wrote (759)3/2/2001 10:51:18 AM
From: Lighthouse  Read Replies (1) of 798
 
By far, Quanam Medical Corporation is the best of the recent acquisitions IMHO. It is the only acquisition announcement to be followed by any buying that I have seen.

The initial clinical results from JNJ's drug coated stent have been outstanding. If the results hold up over time, "Drug Coated Stents" will quickly rout all older stent models. BSX is in this game.

JNJ is in the lead . . . . BSX just cemented their second place amoung the majors (and they have their internal taxol stent as well).

A good balance sheet can help a lot on new product developments. The deleveraging of last year had some positive effects for this year.

I also like the fact that they have not announced a deal to buy Medinol.

Cheers,
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext